Literature DB >> 33322150

SARS-COV-2 Serological Profile in Healthcare Professionals of a Southern Italy Hospital.

Armando De Carlo1, Sergio Lo Caputo1,2, Carmela Paolillo2, Anna Maria Rosa1, Umberto D'Orsi1, Maria De Palma1, Pierluigi Reveglia2, Donato Lacedonia1,3, Gilda Cinnella1,3, Maria Pia Foschino1,3, Maurizio Margaglione1,2, Lucia Mirabella1, Teresa Antonia Santantonio1,2, Gaetano Corso1,2, Vitangelo Dattoli1.   

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the first coronavirus that has caused a pandemic. Assessing the prevalence of anti-SARS-CoV-2 in healthcare worker groups offers a unique opportunity to study the correlation between seroconversion and immunization because of their occupational exposure and a higher risk of contagion. The study enrolled 3242 asymptomatic employees of "Policlinico Riuniti", Foggia. After the first screening, we collected sequential serum samples for up to 23 weeks from the same subjects. In order to perform a longitudinal follow-up study and get information about the titration of IgG levels, we analyzed data from subjects (33) with at least two consecutive serological IgG-positive tests; 62 (1.9%; 95% CI: 1.4-2.3) tested positive for at least one anti-SARS-CoV-2 antibody. The seroprevalence was lower in the high-risk group 1.4% (6/428; 95% CI: 0.5-2.6) vs. the intermediate-risk group 2.0% (55/2736; 95% CI: 1.5-2.5). Overall, within eight weeks, we detected a mean reduction of -17% in IgG levels. Our data suggest a reduction of about 9.27 AU/mL every week (R2 = 0.35, p = 0.0003). This study revealed the prevalence of SARS-CoV-2 antibodies among Foggia's hospital healthcare staff (1.9%). Moreover, the IgG level reduction suggests that the serological response fades fast in asymptomatic infections.

Entities:  

Keywords:  COVID-19; SARS-CoV-2; asymptomatic; healthcare worker; seroprevalence; surveillance

Year:  2020        PMID: 33322150     DOI: 10.3390/ijerph17249324

Source DB:  PubMed          Journal:  Int J Environ Res Public Health        ISSN: 1660-4601            Impact factor:   3.390


  7 in total

1.  Comparison of Four Systems for SARS-CoV-2 Antibody at Three Time Points after SARS-CoV-2 Vaccination.

Authors:  Jong Do Seo; Minjeong Nam; Tae Hwan Lee; Yeon-Sun Ahn; Seon-Hyeon Shin; Hye Young Han; Hee-Won Moon
Journal:  Diagnostics (Basel)       Date:  2022-05-29

2.  Second round statewide sentinel-based population survey for estimation of the burden of active infection and anti-SARS-CoV-2 IgG antibodies in the general population of Karnataka, India, during January-February 2021.

Authors:  M Rajagopal Padma; Prameela Dinesh; Rajesh Sundaresan; Siva Athreya; Shilpa Shiju; Parimala S Maroor; R Lalitha Hande; Jawaid Akhtar; Trilok Chandra; Deepa Ravi; Eunice Lobo; Yamuna Ana; Prafulla Shriyan; Anita Desai; Ambica Rangaiah; Ashok Munivenkatappa; S Krishna; Shantala Gowdara Basawarajappa; H G Sreedhara; K C Siddesh; B Amrutha Kumari; Nawaz Umar; B A Mythri; K M Mythri; Mysore Kalappa Sudarshan; Ravi Vasanthapuram; Giridhara R Babu
Journal:  IJID Reg       Date:  2021-10-30

Review 3.  SARS-CoV-2 seroprevalence around the world: an updated systematic review and meta-analysis.

Authors:  Mobin Azami; Yousef Moradi; Asra Moradkhani; Abbas Aghaei
Journal:  Eur J Med Res       Date:  2022-06-02       Impact factor: 4.981

4.  SARS-CoV-2 Gamma and Delta Variants of Concern Might Undermine Neutralizing Activity Generated in Response to BNT162b2 mRNA Vaccination.

Authors:  Luigia Trabace; Lorenzo Pace; Maria Grazia Morgese; Isabel Bianca Santo; Domenico Galante; Stefania Schiavone; Dora Cipolletta; Anna Maria Rosa; Pierluigi Reveglia; Antonio Parisi; Paolo Tucci; Giovanni Pepe; Rodolfo Sacco; Maria Pia Foschino Barbaro; Gaetano Corso; Antonio Fasanella
Journal:  Viruses       Date:  2022-04-15       Impact factor: 5.818

5.  Seroprevalence of SARS-CoV-2 in unselected surgical patients: An update from an unicentric regional study.

Authors:  Federico Cappellacci; Giacomo Anedda; Stefano Del Giacco; Ferdinando Coghe; Riccardo Cappai; Gian Luigi Canu; Enrico Erdas; Pietro Giorgio Calò; Fabio Medas; Davide Firinu
Journal:  Ann Med Surg (Lond)       Date:  2021-05-04

6.  Seroprevalence of SARS-CoV-2 in a Large Cohort of Italian Police Officers.

Authors:  Sergio Garbarino; Alexander Domnich; Elisabetta Costa; Irene Giberti; Stefano Mosca; Cristiano Belfiore; Fabrizio Ciprani; Giancarlo Icardi
Journal:  Int J Environ Res Public Health       Date:  2021-11-20       Impact factor: 3.390

7.  SARS-CoV-2 Infection in Health Workers: Analysis from Verona SIEROEPID Study during the Pre-Vaccination Era.

Authors:  Stefano Porru; Maria Grazia Lourdes Monaco; Angela Carta; Gianluca Spiteri; Marco Parpaiola; Andrea Battaggia; Giulia Galligioni; Beatrice Ferrazzi; Giuliana Lo Cascio; Davide Gibellini; Angelo Peretti; Martina Brutti; Stefano Tardivo; Giovanna Ghirlanda; Giuseppe Verlato; Stefania Gaino; Denise Peserico; Antonella Bassi; Giuseppe Lippi
Journal:  Int J Environ Res Public Health       Date:  2021-06-14       Impact factor: 3.390

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.